HGTD-P Antibodies

Santa Cruz Biotechnology features a diverse variety of HGTD-P monoclonal antibodies for advanced research in protein studies. HGTD-P monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HGTD-P, or Human Glutamate Transporter D, plays a crucial role in regulating glutamate levels in the central nervous system, which is essential for maintaining synaptic function and preventing excitotoxicity. Dysregulation of HGTD-P has been implicated in various neurological disorders, making it a significant target for research aimed at understanding and treating these conditions. Understanding HGTD-P function and regulation can provide valuable insights into neurological disease mechanisms and potential therapeutic strategies. Researchers studying HGTD-P can uncover new pathways and mechanisms involved in glutamate transport and neural signaling. Advanced research with HGTD-P monoclonal antibodies enables precise detection and characterization of protein expression patterns and interactions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of HGTD-P and its role in neurological health and disease.